This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

René Thürmer, PhD
Deputy Head at BfArM Federal Institute for Drugs & Medical Devices
Speaker

Profile

BfArM - Federal Institute for Drugs and Medical Devices, Germany

Dr. René Thürmer received his diploma in chemistry and his Ph.D. in biochemistry from the University of Tübingen. He joined the BfArM (Federal Institute for Drugs and Medical Devices, Bonn, Germany) in 2000. He currently serves as a CMC reviewer and is Deputy Head of the Unit Pharmaceutical Biotechnology.

His experience is in the field of formulation, manufacture and control of medicinal products, in particular in the field of oligonucleotides, peptides, proteins, liposomes, sustained release polymer drug products, depot formulations, polymer-conjugated drug products, natural and synthetic surfactants, nanomedicine and others.

He is a member of the EMA Quality Innovation Group (QIG) established in 2022.

Agenda Sessions

  • An Update on EMA Regulatory Guidelines for Oligonucleotides

    14:00
  • An Update on EMA Regulatory Guidelines for Peptides

    14:00